Roger Godsiff – 2016 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Roger Godsiff on 2016-09-02.
To ask the Secretary of State for Health, for what reason the decision was taken that NHS England will in future fund only one stem cell transplant for blood cancer patients; what estimate he has made of the number of patients who will be affected by that decision; and what assessment he has made of the potential effect of that policy change on blood cancer survival rates.
David Mowat
The provision of second stem cell transplants was considered as part of NHS England’s annual prioritisation process by the Specialised Commissioning Oversight Group (SCOG). Decisions by SCOG are based on recommendations made by Clinical Priorities Advisory Group (CPAG) which uses a defined process to prioritise treatments based on a combination of cost and patient benefit.
NHS England announced on 2 August that CPAG will re-run the prioritisation process to include proposals previously prioritised in levels 3, 4 and 5. The re-run of the prioritisation process is expected to take place later in the year. Until the process is completed clinicians, on behalf of their patients can continue to apply for funding for second transplant for relapsed disease where there is clinically exceptional or clinically critical need.
